Back to resultsEffects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Primary Purpose
Opioid-Related Disorders, Substance-Related Disorders
Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Dextromethorphan
Sponsored by
About this trial
This is an interventional treatment trial for Opioid-Related Disorders focused on measuring opiate dependence
Eligibility Criteria
Please contact site for information.
Sites / Locations
- University of Pennsylvania
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00000352
First Posted
September 20, 1999
Last Updated
January 11, 2017
Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
University of Pennsylvania
1. Study Identification
Unique Protocol Identification Number
NCT00000352
Brief Title
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
Official Title
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients
Study Type
Interventional
2. Study Status
Record Verification Date
August 1997
Overall Recruitment Status
Completed
Study Start Date
December 1996 (undefined)
Primary Completion Date
February 1998 (Actual)
Study Completion Date
April 1998 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
National Institute on Drug Abuse (NIDA)
Collaborators
University of Pennsylvania
4. Oversight
5. Study Description
Brief Summary
The purpose of this study is to determine if addition of dextromethorphan to a stable dose of methadone in opioid dependent subjects will significantly affect physical and psychological aspects of opioid tolerance.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Opioid-Related Disorders, Substance-Related Disorders
Keywords
opiate dependence
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Enrollment
0 (false)
8. Arms, Groups, and Interventions
Intervention Type
Drug
Intervention Name(s)
Dextromethorphan
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Please contact site for information.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charles O'Brien, M.D., Ph.D.
Organizational Affiliation
PDVAMC Treatment Research Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Pennsylvania
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19104 6178
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1
We'll reach out to this number within 24 hrs